UniProt I2X0X3
30S ribosomal protein S14 (I2X0X3)
30S ribosomal protein S14 (UniProt I2X0X3): 9 experimental structures on GenesisL1, 19 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- I2X0X3
- Protein
- 30S ribosomal protein S14
- Experimental structures
- 9
- Predicted models
- 0
- Pockets
- 19 · 8 records with a druggable one
Structures
9 records of I2X0X3 in the MolNFT archive: 9 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 6VZ3 | Escherichia coli transcription-translation complex D2 (TTC-D2) containing mRNA with a 27 nt long… | electron microscopy | S | — | 2 (best 0.84) |
| 6WD0 | Cryo-EM of elongating ribosome with EF-Tu*GTP elucidates tRNA proofreading (Cognate Structure I-A) | electron microscopy | S | — | 3 (best 0.86) |
| 6WD2 | Cryo-EM of elongating ribosome with EF-Tu*GTP elucidates tRNA proofreading (Cognate Structure II-A) | electron microscopy | S | — | 2 (best 0.85) |
| 6WD3 | Cryo-EM of elongating ribosome with EF-Tu*GTP elucidates tRNA proofreading (Cognate Structure II-B1) | electron microscopy | S | — | — |
| 6WD4 | Cryo-EM of elongating ribosome with EF-Tu*GTP elucidates tRNA proofreading (Cognate Structure II-B2) | electron microscopy | S | — | 3 (best 0.86) |
| 6WD5 | Cryo-EM of elongating ribosome with EF-Tu*GTP elucidates tRNA proofreading (Cognate Structure II-C1) | electron microscopy | S | — | 2 (best 0.86) |
| 6WD7 | Cryo-EM of elongating ribosome with EF-Tu*GTP elucidates tRNA proofreading (Cognate Structure II-D) | electron microscopy | S | — | 2 (best 0.86) |
| 6WD9 | Cryo-EM of elongating ribosome with EF-Tu*GTP elucidates tRNA proofreading (Cognate Structure III-B) | electron microscopy | S | — | 3 (best 0.85) |
| 6WDA | Cryo-EM of elongating ribosome with EF-Tu*GTP elucidates tRNA proofreading (Cognate Structure III-C) | electron microscopy | S | — | 2 (best 0.86) |
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.